Is tirzepatide stronger than semaglutide?
In trials tirzepatide produced greater average weight loss, likely because it acts on two pathways. Stronger on average does not mean better for every person.
Former.Health
Semaglutide vs tirzepatide, how they differ, what trials show on weight loss and side effects, and how a provider decides which fits you.
Semaglutide and tirzepatide are both GLP-1 based medications used for weight management, but tirzepatide works on two hormone pathways instead of one, and in trials it tends to produce somewhat greater average weight loss. Neither is best for everyone. A licensed provider decides which fits your health, history and goals.
Semaglutide is a GLP-1 receptor agonist that acts on one gut hormone pathway. Tirzepatide is a dual GLP-1 and GIP agonist, which is why many people see a stronger appetite effect. Both are weekly injections that are titrated up slowly.
In the STEP trial program, adults on semaglutide lost on average around 15 percent of body weight over about 68 weeks, as reported in the New England Journal of Medicine in 2021. In SURMOUNT-1, adults on the highest tirzepatide dose lost on average about 20 to 22 percent over 72 weeks, as reported in the New England Journal of Medicine in 2022. These are trial averages. Individual results vary and depend on dose, consistency and habits.
Both share a similar side effect profile, mostly gastrointestinal. Nausea, diarrhea, constipation and reduced appetite are often strongest when starting or increasing the dose and may ease over time. Slow titration and provider guidance help keep them manageable. Some people tolerate one medication better than the other.
This is a clinical decision, not a self-diagnosis. A provider weighs your health history, current medications, tolerance, goals and response. What matters as much as the molecule is the habits and coaching around it, which is why Former Health pairs physician-guided care with certified coaching.
In trials tirzepatide produced greater average weight loss, likely because it acts on two pathways. Stronger on average does not mean better for every person.
Sometimes yes, based on results and side effects, decided with your provider, never on your own.
Weight often returns when either is stopped without other support. Building habits during treatment protects the result.
Semaglutide vs tirzepatide, how they differ, what trials show on weight loss and side effects, and how a provider decides which fits you.
Public, indexable information page. Visit Former.Health to review program details, patient information, and available next steps.